Cardiovascular Hazards of Abacavir- Versus Tenofovir-Containing Antiretroviral Therapies: Insights From an Analysis of the REPRIEVE Trial Cohort
Related Posts
Erlandson KM, Umbleja T, Ribaudo HJ, Lu MT, Taron J, Diggs MR, Douglas PS, Fitch KV, Fichtenbaum CJ, Zanni MV, Aberg JA, Rodriguez-Barradas MC, Breaux[...]
Hou J, Haslund-Gourley B, Diray-Arce J, Hoch A, Rouphael N, Becker PM, Augustine AD, Ozonoff A, Guan L, Kleinstein SH, Peters B, Reed E, Altman[...]
Green-Lott AY, Wadhwa A, Bailey AV, Kwan L, Haroldsen CL, Shelton JB, Lewis MS, Beenhouwer DO, Chamie K, Rose BS, Maxwell KN, Nickols NG, Yamoah[...]